A review on the recent advances and application of vaccines against fish pathogens in aquaculture

H Mondal, J Thomas - Aquaculture international, 2022 - Springer
Globally, aquaculture has faced serious economic problems due to bacterial, viral, and
various other infectious diseases of different origins. Even though such diseases are being …

Vaccines for COVID-19

JS Tregoning, ES Brown… - Clinical & …, 2020 - academic.oup.com
Since the emergence of COVID-19, caused by the SARS-CoV-2 virus at the end of 2019,
there has been an explosion of vaccine development. By 24 September 2020, a staggering …

Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization

N Wang, M Chen, T Wang - Journal of Controlled Release, 2019 - Elsevier
Liposomes are widely utilized as a carrier to improve therapeutic efficacy of agents thanks to
their merits of high loading capacity, targeting delivery, reliable protection of agents, good …

The role of nanotechnology in the treatment of viral infections

L Singh, HG Kruger, GEM Maguire… - Therapeutic …, 2017 - journals.sagepub.com
Infectious diseases are the leading cause of mortality worldwide, with viruses in particular
making global impact on healthcare and socioeconomic development. In addition, the rapid …

Liposomes, transfersomes and niosomes: Production methods and their applications in the vaccinal field

D Riccardi, L Baldino, E Reverchon - Journal of Translational Medicine, 2024 - Springer
One of the most effective strategies to fight viruses and handle health diseases is
vaccination. Recent studies and current applications are moving on antigen, DNA and RNA …

Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review

S Das, SS Kar, S Samanta, J Banerjee, B Giri… - Immunologic …, 2022 - Springer
SARS-CoV-2 is an RNA virus that was identified for the first time in December 2019 in
Wuhan, China. The World Health Organization (WHO) labeled the novel coronavirus …

Recombinant vaccines and the development of new vaccine strategies

IP Nascimento, LCC Leite - Brazilian journal of medical and biological …, 2012 - SciELO Brasil
Vaccines were initially developed on an empirical basis, relying mostly on attenuation or
inactivation of pathogens. Advances in immunology, molecular biology, biochemistry …

Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses

JJ Moon, H Suh, A Bershteyn, MT Stephan, H Liu… - Nature materials, 2011 - nature.com
Vaccines based on recombinant proteins avoid the toxicity and antivector immunity
associated with live vaccine (for example, viral) vectors, but their immunogenicity is poor …

Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses

MO Oyewumi, A Kumar, Z Cui - Expert review of vaccines, 2010 - Taylor & Francis
The development of novel immune adjuvants is emerging as a significant area of vaccine
delivery based on the continued necessity to amplify immune responses to a wide array of …

Engineering nano‐and microparticles to tune immunity

JJ Moon, B Huang, DJ Irvine - Advanced materials, 2012 - Wiley Online Library
The immune system can be a cure or cause of disease, fulfilling a protective role in attacking
cancer or pathogenic microbes but also causing tissue destruction in autoimmune disorders …